Myles Wolf, MD, MMSc selected as the next Chief of Duke Nephrology
Myles Wolf, MD, MMSc will assume the role of the Chief of the Division of Nephrology effective August 1, 2016.
Currently, Dr. Wolf is Margaret Gray Morton Professor of Medicine-Nephrology at the Northwestern University Feinberg School of Medicine, where he also is founding director of the Center for Translational Metabolism and Health in the Institute for Public Health and Medicine.
Myles was chosen for this leadership role after a rigorous international search. He presented an exciting vision for the Division of Nephrology, which has a history steeped in success: “To leverage translational multidisciplinary science to unlock the full potential of Duke Nephrology.” Read the full announcement at the Duke Department of Medicine MedicineNews blog.
The mission of Duke Nephrology is to combine the delivery of outstanding clinical services with world-class research and teaching. To this end, the programs in the division are structured to address the most pressing needs facing patients with kidney disease.
Areas of emphasis include the treatment of end-stage renal disease, transplantation, hypertension, cardiovascular disease, glomerular disease, education and bone/ mineral metabolism.
Train with us
The Duke Nephrology fellowship training program excels in all aspects of nephrology, including renal replacement therapy, glomerular disorders, electrolyte abnormalities, transplantation, hypertension, education, global health, informatics, and clinical and basic science research. We offer a 2 year track that features a clinical concentration in an area of interest or a 3-4 year track focusing on traditional research, education or informatics.
Duke Nephrology is home to the Duke O'Brien Center for Kidney Research (DOCK). A P30 grant from the NIDDK, coupled with institutional support from the Duke University School of Medicine and Department of Medicine. Our goal is to unravel the mechanisms underlying the profound impact kidney disease imparts on cardiovascular morbidity and mortality by exploring how kidney disease interacts with the cardiovascular system with genetic, basic science, translational approach.